Showing posts with label Green Pharma Summit. Show all posts
Showing posts with label Green Pharma Summit. Show all posts

Monday, July 13, 2009

Countdown to Green Pharma

The latest LinkedIn Update for the Green Pharma Summit LinkedIn group went out this morning! As we're gearing up for the event next week, we thought you'd like to know what will be happening at the event! If you'll be at the event, use #greenpharma when you Twitter so we can follow along with you at the event!

Read the newsletter here:
http://www.iirusa.com/upload/wysiwyg/New%20Media/LINewsletter071009.htm


The Green Pharma Summit is about how Pharma is going green. Pharmaceutical companies are discovering that going green is not just for altruistic reasons, but that going green actually has benefits to the bottom line. Going green saves and makes money. If you'd like to network with other professionals who are working in the Green Pharma field, join our Green Pharma LinkedIn Group!


Share this article with your social network, just click below to share now!


Thursday, June 18, 2009

The Pharma Industry and Energy Usage

Pharmaceutical companies implementing environmental sustainability initiatives stand to gain immediate cost savings. These savings will not take years to appreciate; tremendous cost savings can be seen within the first 12 months. Here’s a snapshot of just some of the cost savings pharmaceutical companies have experienced in their first year of initiating sustainability programs:

• A pharmaceutical company making a strong move towards green chemistry has the potential to see up to a 40% hazardous waste reduction in one year.
• AstraZeneca’s green chemistry efforts have lowered their material and energy costs, reducing the cost of API generation by 80%
• Baxter’s EHS programs have generated cost savings of $4.4 million
• A recent in-depth analysis of Novartis’s energy efficiency and waste reduction programs have shown that the $20 million dollar investment was recouped in 10 months
• Novartis’s energy efficient pilot project for Penicillin V production has delivered annual cost savings of $5.1 million

In such troubling economic times, the millions of dollars in cost savings through going green will have a tremendous impact on your company’s bottom line and with shareholders. The Green Pharma Summit gathers the pharma industry’s green leaders, who will share with you successful strategies to implement sustainability programs so that your company can start benefiting from cost savings and efficiency improvements right away.


The Green Pharma Summit is about how Pharma is going green. Pharmaceutical companies are discovering that going green is not just for altruistic reasons, but that going green actually has benefits to the bottom line. Going green saves and makes money. If you'd like to network with other professionals who are working in the Green Pharma field, join our Green Pharma LinkedIn Group!


Share this article with your social network, just click below to share now!


Wednesday, June 10, 2009

Sustainable Syntheses

Ann M. Thayer of Chemical and Engineering News reports that pharmaceutical and fine chemicals manufacturers will see benefits if they begin developing greener processes. According to her article, "Process chemistry and green chemistry have common goals: generating less waste and emissions, minimizing material and energy use, and operating more safely under more benign conditions. Greater attention to reagent, solvent, and reaction choices by these chemists is making process development even greener."

By sharing their knowledge of green practices with pharmaceutical industry, pharma may learn new processes that could save more than just a few dollars.

Sustainable Syntheses



The Green Pharma Summit is about how Pharma is going green. Pharmaceutical companies are discovering that going green is not just for altruistic reasons, but that going green actually has benefits to the bottom line. Going green saves and makes money. If you'd like to network with other professionals who are working in the Green Pharma field, join our Green Pharma LinkedIn Group!


Share this article with your social network, just click below to share now!


Thursday, May 28, 2009

US wants to paint the world white to save energy

According to Yahoo.com, US Energy Secretary Steven Chu said Tuesday the Obama administration wanted to paint roofs an energy-reflecting white, as he took part in a climate change symposium in London. For people who found white hard on the eye, scientists had also developed "cool colours" which looked to the human eye like normal ones, but reflect heat like pale colours even if they are darker shades.

And painting cars in cool or light colours could deliver considerable savings on energy use for air conditioning units, he said.


The Green Pharma Summit is about how Pharma is going green. Pharmaceutical companies are discovering that going green is not just for altruistic reasons, but that going green actually has benefits to the bottom line. Going green saves and makes money. If you'd like to network with other professionals who are working in the Green Pharma field, join our Green Pharma LinkedIn Group!


Share this article with your social network, just click below to share now!


Thursday, May 21, 2009

Green Pharma Summit: Who you're going to hear from

Who is going to be at this year's Green Pharma Summit?

Over 20 Leading Pharmaceutical and Industry sustainability experts providing you with green strategies and tools that you can implement immediately upon your return:

Pharma/Biotech
• Michael Whaley, Director of Environmental Health and Safety, Allergan
• Ann Lee-Jeffs, Manager, Worldwide Environmental Affairs, Johnson & Johnson
• Ingrid Mergelsberg, PhD, Director, Chemical and Physical Sciences (Chemical Development), Schering -Plough Research Institute
• Concepcion Jimenez-Gonzalez, PhD, Director, Operational Sustainability, GlaxoSmithKline
• Peter Dunn, PhD, Green Chemistry Team Leader, Pfizer
• Marcus Chung, MBA, Director, Corporate Citizenship, McKesson Corporation
• James Hagan, Vice President, Corporate Environment, Health, Safety and Sustainability, GlaxoSmithKline
• Norman Goldschmidt, Principal, Pharma Engineering Advisors, and Former Sr. Director of Global Engineering & Design, Bristol-Myers Squibb

Government
• Chen Wen, Office of Prevention, Pesticides and Toxics, US Environmental Protection Agency
• Ã…ke Wennmalm, MD, PhD, Professor, Environmental Director, Stockholm County Council
• Michael Gonzalez, National Risk Management Research Lab, US Environmental Protection Agency
• Walt Tunnessen, National Program Director for the EPA Energy Star® Program, US Environmental Protection Agency

Academia
• Terrence J. Collins, PhD, Thomas Lord Professor of Chemistry, Director, Institute for Green Science, Carnegie Mellon University
• William Trombetta, Professor of Marketing, St. Joseph’s University

Enviromental Guru Keynote
• Kim Carlson, Founder, Earthsmart Consumer and author of Green Your Work: Boost Your Bottom Line While Reducing Your Carbon Footprint

The Green Pharma Summit is about how Pharma is going green. Pharmaceutical companies are discovering that going green is not just for altruistic reasons, but that going green actually has benefits to the bottom line. Going green saves and makes money. If you'd like to network with other professionals who are working in the Green Pharma field, join our Green Pharma LinkedIn Group!


Share this article with your social network, just click below to share now!


Monday, May 18, 2009

Zero discharge policy can earn Pharma a few dollars

Recently in the Business Standard, B Krishna Mohan wrote about how some companies are taking their waste and selling it for profit. Waste discharged while making Pharmaceuticals can be turned around and used as raw materials in other industries, which can often be purchased at up to a 50% discount. Some companies have even gone as far as to call for a zero-discharge policy, which eliminates all liquid discharge.

Virchow Laboratories sells sodium sulphate, gypsum, solvents and flyash generated at the company’s Hyderabad and Visakhapatnam bulk drug manufacturing units. While sodium sulphate is the raw material for the soap and detergent industry, gypsum finds use in the cement industry and solvents are the key raw materials for the paint industry. The fly-ash is used for makin
g bricks, says Virchow chairman M Narayana Reddy.

Read the full article here. If you're interested in networking with other professionals who are interested in Green Pharma, join our Green Pharma LinkedIn group and Follow us on Twitter!


Share this article with your social network, just click below to share now!


Monday, April 13, 2009

Web Seminar: The Role of PharmEcovigilance in Reducing the Environmental Footprint of Pharmaceuticals

We'd like to remind you about the web seminar for the Green Pharma Summit

Web Seminar: The Role of PharmEcovigilance in Reducing the Environmental Footprint of Pharmaceuticals

Ilene S Ruhoy, MD, PhD, Assistant Professor, Touro University and US EPA Environmental Sciences Division

Tuesday, April 14, 2009 12:00 PM - 1:00 PM EDT

The prescribing and usage of medications have ramifications extending far beyond conventional medical care. The pharmaceutical and healthcare industries have an environmental footprint because the active pharmaceutical ingredients (APIs) can enter the environment as contaminants by a variety of routes, primarily from excretion, bathing, and disposal. Disposal of unwanted, leftover medications by flushing into sewers has been considered a secondary route - - one that supposedly does not contribute substantially to overall environmental loadings of APIs. This presentation is an examination of secondary routes of API release to the environment and for direct but unintentional human exposure. These routes include: (a) bathing, washing, and laundering, and (b) disposal of unused and partially used high-content medical devices. Understanding these secondary routes is important from the perspective of pollution prevention, as well as for reducing the incidence of unintentional and purposeful poisonings of humans and pets, and for improving the quality and cost-effectiveness of healthcare.

Sign up here:
https://www1.gotomeeting.com/register/909165450

Use priority code:G1M1481W1Blog/LI


Share this article with your social network, just click below to share now!


Thursday, March 12, 2009

Web Seminar: The Role of PharmEcovigilance in Reducing the Environmental Footprint of Pharmaceuticals

Ilene S Ruhoy, MD, PhD, Assistant Professor, Touro University and US EPA Environmental Sciences Division

Tuesday, April 14, 2009 12:00 PM - 1:00 PM EDT

The prescribing and usage of medications have ramifications extending far beyond conventional medical care. The pharmaceutical and healthcare industries have an environmental footprint because the active pharmaceutical ingredients (APIs) can enter the environment as contaminants by a variety of routes, primarily from excretion, bathing, and disposal. Disposal of unwanted, leftover medications by flushing into sewers has been considered a secondary route - - one that supposedly does not contribute substantially to overall environmental loadings of APIs. This presentation is an examination of secondary routes of API release to the environment and for direct but unintentional human exposure. These routes include: (a) bathing, washing, and laundering, and (b) disposal of unused and partially used high-content medical devices. Understanding these secondary routes is important from the perspective of pollution prevention, as well as for reducing the incidence of unintentional and purposeful poisonings of humans and pets, and for improving the quality and cost-effectiveness of healthcare.

Sign up here:
https://www1.gotomeeting.com/register/909165450

Use priority code:G1M1481W1Blog/LI


Share this article with your social network, just click below to share now!


Pharma's pressure to be socially responsible

Future Pharmaceutical recently wrote a article on the variety of ways that Pharma companies are choosing to both protect the environment and show their involvement in both humanitarian and environmental projects. Some of the companies in the article have started using green vehicles for distribution and transportation. Others have made efforts to make meetings greener and another option is to choose sustainable suppliers and sustainable distribution centers.

If you're interested in joining a community of Pharma professionals who are committed to make their Pharma projects that protect the enviornment and are sustainable, join us at the Green Pharma LinkedIn group.


Share this article with your social network, just click below to share now!


Wednesday, February 25, 2009

Green Pharma Summit

Have you heard about the Green Pharma Summit? It'll be taking place July 20-21 in Philadelphia, PA! Find out more information at our webpage and sign up to get the latest updates!

And if you're interested in networking and communicating with other professionals who are working on going green in the Pharma industry, join our Green Pharma LinkedIn Group!


Share this article with your social network, just click below to share now!